Increased polymorphonuclear leukocyte cGMP levels induced by the human lympholine, leukocyte migration inhibitory factor (LIF) (original) (raw)

Increased polymorphonuclear leukocyte cGMP levels induced by the human lymphokine, Leukocyte Migration Inhibitory Factor (LIF)

Klaus Bendtzen

Immunopharmacology, 1979

View PDFchevron_right

Leukocyte migration inhibitory factor: a serine esterase released by stimulated human lymphocytes. Kinetic analysis and inhibition by cyclic GMP

Klaus Bendtzen

Biochimica et biophysica acta, 1979

View PDFchevron_right

Human Leukocyte Migration Inhibitory Factor (LIF).: I. Effect of Synthetic and Naturally Occurring Esterase and Protease Inhibitors

Klaus Bendtzen

Scandinavian Journal of Immunology, 1977

View PDFchevron_right

Production of human leukocyte migration inhibitory factor (LIF) by lymphocytes stimulated with phytohemagglutinin. II. Effects of cyclic nucleotides

Klaus Bendtzen

Clinical immunology and immunopathology, 1981

View PDFchevron_right

Human Leukocyte Migration Inhibitory Factor (LIF)

Klaus Bendtzen

Scandinavian Journal of Immunology, 2008

View PDFchevron_right

The two-step leukocyte migration inhibition factor (LIF) assay

Sara Chapman

Cellular Immunology, 1978

View PDFchevron_right

Human Leucocyte Migration Inhibitory Factor (LIF)

Klaus Bendtzen

Scandinavian Journal of Immunology, 1978

View PDFchevron_right

Inhibition of Human Leukocyte Migration Inhibitory Factor (Lif) by ?-L-Fucose

Klaus Bendtzen

Allergy, 1975

View PDFchevron_right

Production of human leukocyte migration inhibitory factor (LIF) by lymphocytes stimulated with phytohemagglutinin

Klaus Bendtzen

Clinical Immunology and Immunopathology, 1981

View PDFchevron_right

The production of heterologous antibodies to the human lymphokine: Leukocyte migration inhibitory factor (LIF)

Klaus Bendtzen

Cellular Immunology, 1977

View PDFchevron_right

An in Vitro Assay of Leukocyte Migration Inhibitory Activity from Human Lymphocytes Stimulated with Concanavalin a

Klaus Bendtzen

Allergy, 1975

View PDFchevron_right

Production of leukocyte migration inhibitory factor (LIF) in human lymphocyte subsets exposed to polyclonal activators

Maria Masucci

Cellular Immunology, 1984

View PDFchevron_right

Partial purification of human leucocyte migration inhibitory factor (LIF) by immunosorption of supernatant protein contaminants detected by crossed immunoelectrophoresis

Klaus Bendtzen

Journal of Immunological Methods, 1976

View PDFchevron_right

Affinity chromatography. A new technique for partial purification of human leucocyte migration inhibitory factor

Klaus Bendtzen

Journal of Immunological Methods, 1976

View PDFchevron_right

The effect of cyclic GMP and cyclic AMP on migration by electroporated human neutrophils

Jan Elferink

European Journal of Pharmacology: …, 1993

View PDFchevron_right

Leucocyte Migration Inhibitory Activity of Concanavalin-A-stimulated Lymphocytes

Bjørn Søeberg

Acta Medica Scandinavica, 1977

View PDFchevron_right

Characterization of four lymphocyte activation products of guinea pig and their association with macrophage Migration Inhibitory Activity (MIF)

Clemens Sorg

Molecular Immunology, 1980

View PDFchevron_right

The role of cyclic nucleotides in neutrophil migration

Jan Elferink

General Pharmacology-the Vascular System, 1996

View PDFchevron_right

Cyclic nucleotide-induced migration of electropermeabilized neutrophils: The effect of phosphodiesterase-resistant analogues

Jan Elferink

Inflammation Research, 1997

View PDFchevron_right

The Effect of Sodium Aurothiomalate on Stimulated and Non-Stimulated Migration by Human Neutrophils: The Role of Cyclic GMP

Jan Elferink

Inflammation, 1997

View PDFchevron_right

Guinea pig transfer factor: restriction of macrophage migration inhibitory activity to extraordinary dilution confirmed with demonstration of diminished potency of stored preparations

Caroline Whitacre

Clinical immunology and immunopathology, 1979

View PDFchevron_right

The effect of histamine on leukocyte migration test in man

Gilbert Souweine

Cellular Immunology, 1979

View PDFchevron_right

Inhibition of leukocyte chemotaxis by Glu-Glu-Glu-Glu-Tyr-Pro-Met-Glu and Leu-Ile-Glu-Asp-Asn-Glu-Tyr-Thr-Ala-Arg-Gln-Gly

Fusao Hirata

Biochemical and Biophysical Research Communications, 1984

View PDFchevron_right

Immunohistochemical demonstration of migration inhibitory factor (MIF) in experimental allergic contact dermatitis

Clemens Sorg

PubMed, 1988

View PDFchevron_right

Inhibition of the transendothelial migration of human lymphocytes but not monocytes by phosphodiesterase inhibitors

B. Ferry

Clinical and Experimental Immunology, 1996

View PDFchevron_right

Migration Enhancement Factor: A New Lymphokine

Leonard Goldberg

Proceedings of the National Academy of Sciences, 1974

View PDFchevron_right

Influence of endotoxin on production of leucocyte migration inhibition factor. Part I

Klaus Bendtzen

Journal of Immunological Methods, 1984

View PDFchevron_right

Investigation of the role of nitric oxide and cyclic GMP in both the activation and inhibition of human neutrophils

payong wanikiat

British Journal of Pharmacology, 1997

View PDFchevron_right

The appearance of macrophage migration-inhibition factor in drug reactions

S. Halevy

Journal of Allergy and Clinical Immunology, 1987

View PDFchevron_right

The effect of pentoxifylline on human neutrophil migration: A possible role for cyclic nucleotides

Jan Elferink

Biochemical Pharmacology, 1997

View PDFchevron_right

Specific binding of B-CLL cell-derived chemokinetic inhibitory factor (CIF) to human polymorphonuclear leukocytes

Per Venge

European Journal of Haematology, 2009

View PDFchevron_right